Quantitative Information in Direct-to-Consumer Television Advertisements Survey

Forms and Documents

Document Name	Status
OMB FINAL SUPPORTING STATEMENT PART B 3-31-2016.doc Supporting Statement B	2016-03-31
OMB SUPPORTING STATEMENT PART A FINAL 3-31-2016.doc Supporting Statement A	2016-03-31

IC Document Collections

IC ID	Document Title	Status
220730	Number to Complete the Survey (85%) - Study 2 Other-Survey	New
220729	Number to Complete the Screener (10%) - Study 2 Other-Screener	New
220727	Number to Complete the Survey (85%) - Study 1 Other-Survey	New
220726	Number to Complete the Screener (10%) - Study 1 Other-Screener	New

ICR Details

OMB Control No: 0910-0821	ICR Reference No: 201603-0910-012
Status: Historical Active	Previous ICR Reference No:
Agency/Subagency: HHS/FDA	Agency Tracking No: CDER
Title: Quantitative Information in Direct-to-Consumer Television Advertisements Survey
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 08/01/2016
	Date Received in OIRA: 04/01/2016
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	08/31/2019	36 Months From Approved
Responses	4,826	0	0
Time Burden (Hours)	746	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: This project is designed to test consumers’ understanding of quantitative information about prescription drugs in direct-to-consumer (DTC) television ads. We plan to conduct two 20-minute surveys with adults 60 years or older. In Study 1, 900 participants will be randomly assigned to one of nine test conditions. The conditions will vary by the type of quantitative efficacy information (none, simple, or complex) and the type of quantitative risk information (none, general, or specific) in a DTC television ad for a fictitious prescription drug to treat cataracts. In Study 2, 900 participants will be randomly assigned to one of six test conditions. The conditions will vary by the type of quantitative efficacy information (none, simple) and the type of efficacy images in the ad (none, accurate improvement, overstated improvement) in the same DTC ad as in Study 1. Participants will watch the DTC television ad and then will complete a questionnaire that will include measures of recall, perceptions, attitudes, and intentions.

---

Authorizing Statute(s): US Code: 21 USC 393(b)(2)(c) Name of Law: Federal Food, Drug, and Cosmetic Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	80 FR 61433	10/13/2015
30-day Notice:	Federal Register Citation:	Citation Date:
	81 FR 14855	03/18/2016
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 4

IC Title	Form No.	Form Name
Number to Complete the Screener (10%) - Study 1
Number to Complete the Survey (85%) - Study 1
Number to Complete the Screener (10%) - Study 2
Number to Complete the Survey (85%) - Study 2

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	4,826	0	0	4,826	0	0
Annual Time Burden (Hours)	746	0	0	746	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: This is a new data collection

---

Annual Cost to Federal Government: $321,746

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 04/01/2016

---